Cart
sales@molnova.com
Etamsylate
CAS No. 2624-44-4
Etamsylate( Ethamsylate | E 141 | MD 141 | Aglumin | Altodor | Eselin )
Catalog No. M13801 CAS No. 2624-44-4
Ethamsylate is a haemostatic drug, which inhibits biosynthesis and action of prostaglandins, and increases capillary endothelial resistance as and platelet adhesion.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 10MG | 29 | In Stock |
|
| 25MG | 41 | In Stock |
|
| 50MG | 56 | In Stock |
|
| 100MG | 87 | In Stock |
|
| 200MG | 131 | In Stock |
|
| 500MG | Get Quote | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NameEtamsylate
-
NoteResearch use only, not for human use.
-
Brief DescriptionEthamsylate is a haemostatic drug, which inhibits biosynthesis and action of prostaglandins, and increases capillary endothelial resistance as and platelet adhesion.
-
DescriptionEthamsylate is a haemostatic drug, which inhibits biosynthesis and action of prostaglandins, and increases capillary endothelial resistance as and platelet adhesion.
-
In VitroCell Migration Assay Cell Line:HMEC-1 and HUVECs cells Concentration:0-100 μM Incubation Time:3-8 h Result:Didn’t affect the migration of HMEC-1 cells.Inhibited the migration of HUVECs cells.Thinned the morphology of the closed network and enlarged the closed cells.Western Blot Analysis Cell Line:HUVECs cells Concentration:0-100 μM Incubation Time:48 h Result:Decreased the amount of Akt1 phosphorylated.Decreased pERK2 levels at the highest doses (50-100 μM).
-
In VivoAnimal Model:C57BL/6J female mice of spinal cord injury Dosage:100 mg/kg Administration:Oral gavage (p.o.), twice a day, three days Result:Attenuated the MMP-9 expression.Inhibited the degradation of TJ proteins.Reduced the upregulation of IL-1β, IL-6, and TNF-α.Reduced axonal demyelination and decreased cystic cavity formation.Reduced the extent of Fibrotic scar formation.
-
SynonymsEthamsylate | E 141 | MD 141 | Aglumin | Altodor | Eselin
-
PathwayAutophagy
-
TargetThrombin
-
RecptorThrombopoiesis
-
Research AreaCardiovascular Disease
-
Indication——
Chemical Information
-
CAS Number2624-44-4
-
Formula Weight263.31
-
Molecular FormulaC10H17NO5S
-
Purity>98% (HPLC)
-
SolubilityWater: 53 mg/mL (201.28 mM); DMSO: 53 mg/mL (201.28 mM)
-
SMILESO=S(C1=CC(O)=CC=C1O)(O)=O.CCNCC
-
Chemical NameBenzenesulfonic acid, 2,5-dihydroxy-, compd. with diethylamine
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1.Garay RP, et al. Am J Ther, 2006, 13(3), 236-247.
molnova catalog
related products
-
Dabigatran ethyl est...
Dabigatran ethyl ester hydrochloride is an effective inhibitor of ribosyl dihydronicotinic acid amide dehydrogenase (NQO2) with an IC50 value of 0.8 μM and is a thrombin inhibitor.
-
Melagatran
Melagatran is an orally available, direct synthetic thrombin inhibitor that does not require endogenous cofactors other than thrombin and does not significantly interact with any other enzymes in the coagulation cascade or with the fibrinolytic enzymes.
-
Flovagatran
Flovagatran (TGN 255) is an orally active, potent, and selective inhibitor of thrombin and parenteral direct factor II.Flovagatran is used to study venous thromboembolism.
